TY  - JOUR
T1  - EValuation for coronary artery disease and medicare spending—reply
AU  - Shreibati J, Baker LC, Hlatky MA
Y1  - 2012/03/07
N1  - 10.1001/jama.307.9.912-a
JO  - JAMA
SP  - 911
EP  - 912
VL  - 307
IS  - 9
N2  - 
We would contend, however, that the ultimate measure of the value of CCTA will be its effect on clinical outcomes, not its sensitivity or specificity. Comparative studies with long-term follow-up are needed to compare CCTA with stress testing in the evaluation of patients with suspected CAD.

SN  - 0098-7484
M3  - doi: 10.1001/jama.307.9.912-a
UR  - http://dx.doi.org/10.1001/jama.307.9.912-a
ER  -